---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-027956"
form_type: "8-K"
ticker: "MDGL"
cik: "0001157601"
company_name: "MADRIGAL PHARMACEUTICALS, INC."
filed_at: "2026-04-28T23:59:59+00:00"
generated_at: "2026-05-15T02:43:46.870531+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Madrigal reclassifies two directors to balance board classes ahead of 2026 annual meeting

## Summary
- Julian C. Baker reclassified from Class III to Class I, term expiring at 2026 Annual Meeting.
- Daniel J. Brennan reclassified from Class II to Class I, effective April 22, 2026.
- Reclassification aims to achieve more equal apportionment among three board classes.
- Baker, Brennan, and James Daly nominated for re-election at June 17, 2026 meeting.
- No changes to committee assignments as a result of the reclassification.

## SEC filing metadata
- accession: 0001628280-26-027956
- form_type: 8-K
- ticker: MDGL
- cik: 0001157601
- company_name: MADRIGAL PHARMACEUTICALS, INC.
- filed_at: 2026-04-28T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1157601/000162828026027956/0001628280-26-027956-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1157601/000162828026027956/mdgl-20260422.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-027956
- JSON: https://secwatch.observer/filing/0001628280-26-027956.json
- Plain text: https://secwatch.observer/filing/0001628280-26-027956.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.